Physician profile
Erika Maclin
NPI 1356867774
$7,406.42
in general payments reported to CMS, 2019-2025
35 companies · $1,773 in 2025
The $1,773 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $211 · 2022: $1,655 · 2023: $2,222 · 2024: $1,545 · 2025: $1,773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,498 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,497.96 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,314.01 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $871.17 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Insulet Corporation | $526.37 | 2022-2025 | Omnipod |
| Abbvie INC. | $479.90 | 2022-2025 | |
| Xeris Pharmaceuticals, INC. | $400.12 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Dexcom, INC. | $375.60 | 2021-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $347.76 | 2022-2023 | |
| Amgen INC. | $341.32 | 2023-2025 | Evenity, Prolia, Tepezza |
| Astrazeneca Pharmaceuticals Lp | $268.85 | 2022-2024 | Farxiga |
| Cequr Corporation | $263.57 | 2023-2025 | Cequr Simplicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.42 | 2021-2024 | Synjardy, Jardiance |
| Medtronic, INC. | $237.49 | 2022-2025 | Minimed 780g |
| Abbott Laboratories | $233.19 | 2022-2025 | Freestyle Libre 3 |
| Beta Bionics, INC. | $203.74 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Corcept Therapeutics | $203.23 | 2021-2024 | Korlym |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $185.03 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Mannkind Corporation | $176.06 | 2023-2025 | Afrezza |
| Antares Pharma, INC. | $159.52 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Bayer Healthcare Pharmaceuticals INC. | $97.39 | 2023-2025 | |
| Sequel Med Tech, LLC | $84.35 | 2025 | Twiist |
| Ascendis Pharma Endocrinology INC | $62.99 | 2023-2025 | Yorvipath |
| Ibsa Pharma INC. | $61.93 | 2023-2025 | Licart, Flector, Tirosint |
| Tolmar, INC. | $57.38 | 2024-2025 | Jatenzo |
| Alexion Pharmaceuticals, INC. | $28.38 | 2025 | Ultomiris |
| Merit Medical Systems INC | $25.44 | 2025 | Savi Scout |
| Astellas Pharma US INC | $21.35 | 2025 | Veozah |
| Exeltis, USA INC. | $17.70 | 2023 | Slynd |
| Nevro Corp. | $17.36 | 2023 | Senza |
| Halozyme INC | $17.16 | 2023 | |
| Amphastar Pharmaceuticals, INC. | $16.41 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.22 | 2022 | |
| Millicent US INC | $14.93 | 2022 | |
| Amneal Pharmaceuticals LLC | $14.51 | 2024 | Unithroid |
| Merck Sharp & Dohme LLC | $13.85 | 2022 | |
| Radius Health, INC. | $13.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Maclin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.